Abstract:Objective: To explore the role of tumor necrosis factor receptor-associated factor 4 (TRAF4) in promoting the abnormal activation of epidermal growth factor receptor (EGFR) and its effect on lung cancer cell proliferation, migration and invasion. Methods: Tumor tissues from patients who underwent lung adenocarcinoma resection at The First Affiliated Hospital of Second Military Medical University, from January 2015 to May 2017 were collected, and the expressions of TRAF4 and Ki-67 in lung cancer tissues were detected by immunohistochemistry, the mRNA levels of Cyclin D and Vimentin were detected by real-time fluorescence quantitative PCR (qRT-PCR). The effect of TRAF4 on the tumor growth ability of lung cancer A549 cells was investigated by the xenograft model, the effect of TRAF4 or EGFR on the tumor proliferation ability was detected by using cell counting kit 8 (CCK8) and BrdU assay, and the migration and invasion abilities of tumor cells were detected by Transwell assay. Different structural domain deletion expression vectors of TRAF4 and EGFR were constructed to transfect cells, and the interaction mode of TRAF4 and EGFR was investigated by immunoprecipitation assay. Results: The expression of TRAF4 in non-small cell lung cancer (NSCLC) tissues was positively correlated with the expressions of Ki-67, cyclin D, and vimentin (r2: 0.438, 0.695, and 0.736, respectively, all P＜0.01). Immunohistochemical assay of tumor tissues from NSCLC patients showed that tissues with high expression of TRAF4 were also high in Ki-67. Patients with high TRAF4 expression (TRAF4 positivity >30%) had a shorter progression-free survival (PFS) time than that of patients with low TRAF4 expression (TRAF4 positivity ≤30%) (median PFS of 12 and 19 months, respectively; P=0.034). Traf4-/- cells had a weakened proliferative capacity than traf4+/+ cells and formed tumors with smaller size (P＜0.05). The expression level of Ki-67 in the tumor tissues formed by traf4-/- cells [(45.6±8.7)%] was lower than that in the tumor tissues formed by traf4+/+ cells [(62.3±10.3)%, P=0.015], the mRNA levels of cyclin D (1.01±0.15) and vimentin (1.01±0.12) in the traf4-/- cells were lower than those of the traf4+/+ cells (3.41±0.32 and 3.12±0.18, respectively, both P＜0.05).The western blot results showed that, with the elevated intracellular expression level of TRAF4, phosphorylation level of EGFR was significantly increased in both wild-type EGFR and activation mutant EGFR-expression cells. The capacities of proliferation, migration and invasion of A549 cells was weakened after EGFR knockdown (all P＜0.01). Immunoprecipitation experiments showed that TRAF4 binds to the peptide segment of the near-membrane region of EGFR through the TRAF structural domain, and the mutual binding between EGFR molecules was enhanced under TRAF4 overexpression conditions. Increasing TRAF4 expression promoted EGFR molecular phosphorylation and activation of downstream signaling. Conclusions: TRAF4 expression is elevated in NSCLC tissues and tumor cells, which promotes tumor proliferation, migration and invasion. TRAF4 directly binds to EGFR molecules, enhances its own phosphorylation and activates the downstream signaling pathway by promoting the interaction between EGFR molecules.

[Expression of TR4-associated Protein in Non-Small Cell Lung Cancer].

Expression of Telomeric Repeat Binding Factor 1 in Non-Small Cell Lung Cancer.

Testicular Orphan Nuclear Receptor 4 is Associated with the Radio-Sensitivity of Prostate Cancer.

[Expression of Telomere Repeat Binding Factor 1 (TRF1) Protein in Kidney Cancer].

Testicular orphan nuclear receptor 4-associated protein 16 promotes non-small cell lung carcinoma by activating estrogen receptor β and blocking testicular orphan nuclear receptor 2.

Analysis of the Nuclear Localization Signal of TRF1 in Non-Small Cell Lung Cancer

Abnormal Expression and Clinical Significance of Telomeric Repeat Binding Factor 1 and Tankyrase 1 in Non-small Cell Lung Cancer

[Expression of telomere binding factor 2 (TRF2) on leukemia cell lines and primary leukemia cells].

The Roles and Mechanisms of TRAT1 in the Progression of Non-Small Cell Lung Cancer

Expression of tumor necrosis factor receptor-associated factor 6 in lung cancer tissues.

Expression Of Telomeric Repeat Binding Factor 1 Protein In Nonsmall Cell Lung Cancer With Human Telomerase Reverse Transcriptase Positive

[Expression and Significance of TRAF4 Protein in Breast Carcinoma].

Expression of TRA1 mRNA in hepatocellular carcinoma and liver cirrhosis tissue

TRAT1 overexpression delays cancer progression and is associated with immune infiltration in lung adenocarcinoma

TNF Receptor-Associated Factor 1 As a Biomarker for Assessment of Non-Small Cell Lung Cancer Metastasis and Overall Survival

A comprehensive meta-analysis of tissue resident memory T cells and their roles in shaping immune microenvironment and patient prognosis in non-small cell lung cancer

[TRAF4 promotes lung cancer development by activating tyrosine kinase of EGFR]

Plasma Thioredoxin Reductase Activity, a Diagnostic Biomarker, is Up-Regulated in Resectable Non-Small Cell Lung Cancers

TR4 Nuclear Receptor Promotes Prostate Cancer Metastasis Via Upregulation of CCL2/CCR2 Signaling.

Selective expression of transthyretin in subtypes of lung cancer

Abstract 7323: Tissue resident memory T cell abundances impact non-small-cell lung cancer immune microenvironment and patient prognosis